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Abstract
Introduction
New York City has one of the highest reported death 
rates from coronary heart disease in the United States. We 
sought to measure the accuracy of this rate by examining 
death certificates.
Methods
We conducted a cross-sectional validation study by using 
a random sample of death certificates that recorded in- 
hospital deaths in New York City from January through 
June 2003, stratified by neighborhoods with low, medium, 
and high coronary heart disease death rates. We abstract-
ed data from hospital records, and an independent, blind-
ed  medical  team  reviewed  these  data  to  validate  cause 
of  death.  We  computed  a  comparability  ratio  (coronary 
heart disease deaths recorded on death certificates divided 
by validated coronary heart disease deaths) to quantify 
agreement  between  death  certificate  determination  and 
clinical judgment.
Results
Of 491 sampled death certificates for in-hospital deaths, 
medical charts were abstracted and reviewed by the expert 
panel for 444 (90%). The comparability ratio for coronary 
heart disease deaths among decedents aged 35 to 74 years 
was 1.51, indicating that death certificates overestimated 
coronary heart disease deaths in this age group by 51%. 
The  comparability  ratio  increased  with  age  to  1.94  for 
decedents aged 75 to 84 years and to 2.37 for decedents 
aged 85 years or older.
Conclusion
Coronary  heart  disease  appears  to  be  substantially 
overreported as a cause of death in New York City among 
in-hospital deaths.
Introduction
Coronary heart disease (CHD) is the leading cause of 
death for adults in the United States, and stroke ranks 
third (1). In New York City, an unusual pattern of high 
CHD death rates and low stroke death rates has been 
observed; the age-adjusted CHD death rate in 2003 was 
1.7 times the national rate, and the age-adjusted stroke 
death rate was half the national rate (1,2). This pattern 
is unexpected, given that risk factors for CHD and stroke 
are similar and that the prevalence in New York City of 
most  common  CHD  risk  factors,  such  as  hypertension, 
hyperlipidemia,  obesity,  and  smoking,  is  similar  to  or 
lower than that in the rest of the country (3). New York 
City CHD death rates have been consistently higher than 
national CHD death rates for more than 3 decades despite 
steady CHD death rate declines nationally and in New 
York City (Figure).
Misreporting cause of death on death certificates may be 
contributing to New York City’s observed high CHD death 
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rate. Studies have suggested that such misreporting may 
be common. A study of 2 Texas military hospitals found 
that 37% of death certificates reported a different cause 
of  death  than  did  autopsy  (4).  A  Swedish  study  found 
that 54% of death certificates reported a different cause of 
death than did chart review (5). The level of misreporting 
varies by cause of death. For CHD, a British study found 
that  death  certificates  have  a  low  sensitivity  for  CHD 
deaths  compared  with  autopsy  findings  (6).  A  study  of 
Framingham Heart Study participants found that death 
certificates attributed 24% more deaths to CHD than did 
a physician panel that reviewed medical records (7). The 
Atherosclerosis Risk in Communities (ARIC) study also 
found that death certificates overestimated CHD deaths 
by 20% compared with a physician review panel (8).
We sought to determine whether local physician report-
ing  patterns  of  CHD  on  death  certificates  contribute 
to  the  observed  pattern  of  high-CHD,  low-stroke  death 
rates observed in New York City. Our investigation was 
designed  to  determine  the  accuracy  of  death  certificate 
reporting of CHD as a cause of death in New York City 
by using methods employed by the ARIC study in other 
jurisdictions. We did not directly address accuracy of death 
certificate reporting of stroke in this analysis.
Methods
Study design and population
We developed the study design by using the methods 
of  the  ARIC  study,  which  evaluated  CHD  reporting  on 
death  certificates  in  4  geographically  distinct  US  com-
munities by using a blinded medical record review pro-
cess (8). A completed “determination of research status” 
form was submitted to the Centers for Disease Control 
and Prevention (CDC), which determined that this study 
would not require institutional review board approval. We 
assessed New York City death certificates dated January 
through June 2003, including those for which the dece-
dent 1) was a resident of New York City, 2) died in one 
of the city’s 70 hospitals, and 3) had an underlying cause 
of death on his or her death certificate that corresponded 
to a subset of codes associated with CHD or stroke from 
the International Classification of Diseases, 10th revision 
(ICD-10) and corresponding to the ICD-9 codes used in the 
ARIC validation study (Table 1). A data set with 13,144 
eligible death certificates, including 7,674 for in-hospital 
deaths, was obtained from the New York City Department 
of Health and Mental Hygiene (DOHMH), Bureau of Vital 
Statistics. We took a stratified random sample based on 
New York City neighborhoods with low, medium, or high 
age-adjusted CHD death rates in 2001; each stratum con-
tained roughly one-third of the sampled population. This 
study was restricted to 491 in-hospital deaths to maximize 
feasibility of data collection. In-hospital deaths were cat-
egorized as inpatient, emergency department (ED), outpa-
tient, and dead on arrival (DOA).
Data collection
Hospitals provided medical records for the sampled dece-
dents. We abstracted information from each record and 
entered  it  into  a  standardized  computer-based  abstrac-
tion form developed by using EpiInfo version 3.4.1 (CDC, 
Atlanta, Georgia). This form contained pre-populated fields 
for demographic data reported on the death certificates. 
Information abstracted from the medical chart included 
time from onset of symptoms to death, presence of chest 
pain, history of CHD, and medication use. We photocopied 
electrocardiogram results (ECGs), test results for cardiac 
enzymes, and medical discharge summaries.
External review
Two external teams were assembled, each consisting of 
Figure. Age-adjusted deaths from coronary heart disease in New York City 
(NYC) versus the United States overall. “ICD” indicates the revisions of the 
International Classification of Diseases that were used to categorize cause 
of death. US data for 1950 through 2002 from National Heart, Lung, and 
Blood Institute, 2002. US data for 2003 through 2006 from Centers for 
Disease Control and Prevention. NYC data from NYC Department of Health 
and Mental Hygiene, Bureau of Vital Statistics. NYC population data from 
1971 through 2003 census estimates. NYC population data from 1961 
through 1969 from linear interpolation.VOLUME 7: NO. 3
MAY 2010
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2 physician epidemiologists, trained and certified in the 
ARIC protocol for validation of CHD events. They were 
blinded to the cause of death listed on the death certificate 
and used case summary reports generated from the medical 
record abstraction, ECGs, and medical discharge summa-
ries to answer 5 yes/no questions about each case: 1) Was 
there a known nonatherosclerotic or noncardiac process or 
event that was probably lethal?, 2) Was there a definite 
myocardial infarction (MI) for which the patient was hos-
pitalized within 4 weeks of death?, 3) Was there a probable 
MI for which the patient was hospitalized within 4 weeks 
of death?, 4) Was there a history of chest pain within 72 
hours of death?, and 5) Was there a history of ever having 
had chronic ischemic heart disease such as coronary insuf-
ficiency or angina? When initial responses to questions dif-
fered within each team, the 2 reviewers discussed the case 
until they agreed on a final determination.
Case definitions
Death  certificate  CHD  deaths  were  defined  as  ICD-
10  codes  I20-I25  and  I51.6.  Death  certificate  non-CHD 
deaths were defined as all other ICD-10 codes included in 
the study (Table 1). We used an algorithm based on the 
ARIC methods, incorporating the reviewer responses to 
the 5 yes/no questions described above, to develop 2 defini-
tions of CHD: definite CHD and possible CHD. Definite 
CHD was defined as 1) no known nonatherosclerotic or 
noncardiac  process  or  event  that  was  probably  lethal 
and 2) at least 1 of the following conditions: definite MI 
for which the patient was hospitalized within 4 weeks of 
death, history of chest pain within 72 hours of death, or 
history of chronic ischemic heart disease such as coronary 
insufficiency or angina pectoris. The definite CHD valida-
tion definition relies heavily on information available in 
the medical record. To account for the possibility that a 
death may be due to CHD even if relevant information 
is not clearly documented in the chart, we used a second 
case definition, possible CHD. Possible CHD was defined 
as 1) no known nonatherosclerotic or noncardiac process 
or event that was probably lethal and 2) a death certifi-
cate with a consistent underlying cause of death (ICD-10 
codes I20-I25 and I51.6). This definition is more sensitive, 
excluding only those deaths with a clearly recorded cause 
other than CHD.
Data analysis
The goal of data analysis was to estimate the degree to 
which  CHD  deaths  were  reported  on  death  certificates 
when measured against the standard of external medical 
chart review. To obtain this measurement, we calculated 
comparability ratios (CRs) as the number of CHD deaths 
defined by the death certificate divided by the number of 
CHD deaths defined by review of the medical record. We 
also calculated sensitivity, false-positive rate (FPR), and 
positive predictive value (PPV).
The final data set contained records that were abstract-
ed and validated (n = 444). Observations were assigned 
initial weights equal to their inverse probability of selec-
tion, which varied by strata. The target population con-
sisted  of  all  New  York  City  in-hospital  decedents  with 
sampled ICD-10 codes (n = 7,800) who died during the 
study  period.  We  used  post-stratification  weighting  to 
account for differences in race/ethnicity and sex distribu-
tions between the sample and the target population. To 
account for the complex sampling design, we computed 
variance estimates for CRs by using a jackknife estimator 
for stratified samples (9).
For direct comparison to the ARIC study of inpatient 
deaths (excluding ED, outpatient, and DOA deaths), we 
also  calculated  survey  weights  and  outcome  measures 
for  the  inpatient  subpopulation.  Findings  were  similar 
for the inpatient-only and comprehensive samples; thus, 
detailed  results  are  presented  only  for  the  larger  in- 
hospital sample.
Results
Of the 491 eligible cases, 444 records (90%) were abstract-
ed  from  hospital  charts  and  assessed  by  the  reviewers. 
Charts were unavailable for the remaining 47 cases. Of the 
444 decedents, 345 were inpatients; 70 were ED patients or 
outpatients; 23 were DOA, and 6 died in other or unknown 
places in the hospital (Table 2). Most were women (54%), 
aged 75 years or older (66%), non-Hispanic white (55%), 
and died in a private hospital (89%).
Reviewer disagreement before adjudication on each of 
the 5 validation questions ranged from 5% to 31%. The 
sensitivity of death certificates for definite CHD deaths 
was 0.87, the FPR was 0.66, and the PPV was 0.46 (Table 
3). The overall CR for definite CHD was 1.91 (95% con-
fidence interval [CI], 1.59-2.23). The CR increased with 
age, from 1.51 for decedents aged 35 to 74 years to 2.37 VOLUME 7: NO. 3
MAY 2010
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for decedents aged 85 years or older. The CR was 1.83 for 
women and 2.01 for men; it was 2.08 for whites, 2.14 for 
blacks, and 1.30 for Hispanics. When the broader possible 
CHD  definition  was  used,  the  sensitivity  was  0.91,  the 
PPV was 0.66, and the FPR was 0.54. The CR for possible 
CHD deaths was 1.37 (95% CI, 1.21-1.53).
When data were stratified by neighborhoods with low, 
medium,  and  high  CHD  death  rates,  the  CR  increased 
progressively from low to high strata. The CR for definite 
CHD in the low stratum was 1.82 (95% CI, 1.40-2.24), in 
the medium stratum was 2.06 (95% CI, 1.67-2.45), and 
in the high stratum was 2.79 (95% CI, 2.43-3.15). This 
trend  remained  consistent  in  the  inpatient  population 
(CR range, 1.71-2.80) and when using the “possible CHD” 
validation definition for both the total in-hospital popula-
tion (CR, 1.28-1.99) and the inpatient-only population (CR, 
1.30-2.36).
Discussion
These  results  demonstrate  substantial  overreporting 
of CHD as a cause of death on death certificates in New 
York City for in-hospital deaths, when measured against 
the standard of medical record review. The CR for definite 
CHD was 1.51 for in-hospital decedents and 1.33 for inpa-
tient decedents (in-hospital deaths excluding DOA, outpa-
tient, and ED deaths) aged 35 to 74 years. The inpatient 
population is comparable to the inpatient population in 
the ARIC study, which examined deaths among decedents 
aged 35 to 74 years in 4 other sites across the country. The 
ARIC study found modest underreporting of CHD deaths 
on death certificates compared with chart review by using 
the same validation definition for definite CHD (CR, 0.9). 
These results indicate that overreporting of CHD on death 
certificates  may  contribute  to  the  elevated  CHD  death 
rates observed in New York City.
The  study  design  was  based  on  the  methods  of  the 
ARIC validation study but differs from the ARIC study in 
3 ways. First, the ARIC study was conducted from 1987 
through  1995,  when  ICD-9  was  used  to  code  cause  of 
death, whereas this study was conducted in 2003 by using 
ICD-10  codes.  Given  the  high  correspondence  between 
ICD-9 and ICD-10 for CHD (10), the change in classifica-
tion system is unlikely to account for the differences in the 
CRs between ARIC and this study. Second, stroke deaths 
reported on death certificates were not included in ARIC 
but were included in our study. Including stroke deaths 
could have resulted in a greater opportunity for false or 
true  negatives.  False  negatives  would  have  resulted  in 
a lower CR. However, our sample included only a small 
number of stroke deaths, and all were classified as true 
negatives.  Therefore,  the  inclusion  of  stroke  deaths  did 
not affect our comparison with ARIC. Third, this study 
included a high proportion of decedents aged 75 years or 
older, many of whom had multiple chronic medical prob-
lems; the presence of these comorbidities made validation 
especially  difficult,  as  evidenced  by  the  range  of  initial 
disagreement between the reviewers on the 5 validation 
questions. Difficulty in validating cause of death was also 
due to conflicting, sparse, or missing information in hospi-
tal charts. When reviewers were uncertain how to answer 
a question, they chose “no,” frequently resulting in a vali-
dated “No CHD” classification. This in turn yielded fewer 
validated CHD deaths, possibly inflating the CR.
To our knowledge, this is the first study to examine CHD 
reporting  on  in-hospital  death  certificates  in  New  York 
City. The findings have implications for public health and 
vital registration practice. Further work is needed to bet-
ter understand patterns of death certificate completion for 
in-hospital deaths. Providers who are most knowledgeable 
about the patient do not always complete the death cer-
tificate; that task may be assigned to residents or fellows 
who  are  not  properly  instructed  in  completion,  leading 
to inaccurate reporting (11). In addition, providers who 
complete the death certificate may not have all relevant 
patient information available at that time. In particular, 
physicians in the ED have limited information at the time 
of  death  certificate  completion.  External  reviewers  may 
have had the benefit of pathology or laboratory reports 
unavailable to the provider at the time of death certificate 
completion. Lack of information about DOA, outpatient, 
and ED decedents may account for the difference between 
inpatient and in-hospital CRs.
Other reasons for CHD overreporting on death certificates 
may be more specific to New York City. New York City has 
a central registration process, but the rest of the state has 
approximately 1,500 local registrars, similar to most other 
health jurisdictions. Therefore, any bias in reporting, such 
as  misunderstanding  regarding  how  death  certificates 
should be completed, may be compounded. For example, 
in the past the New York City burial desk rejected death 
certificates for improper completion of cause of death. This 
rejection process no longer occurs, but the fear of having a VOLUME 7: NO. 3
MAY 2010
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death certificate rejected may still lead many physicians to 
complete certificates with common and “acceptable” causes 
of death, such as CHD. Second, New York City requires 
death certificates to be registered within 72 hours of death. 
This time pressure may result in more frequent reporting 
of certain causes of death that are easier to assume in a 
decedent with many comorbidities, such as older decedents. 
Third, the large number of teaching hospitals in New York 
City may compound the problem of providers who are less 
familiar with the decedent’s medical history being respon-
sible for completing death certificates.
This  study  highlights  the  possibility  that  New  York 
City’s observed high rate of CHD may be partly due to mis-
reporting of CHD on death certificates. Death certificate 
accuracy may be improved by physician education. The 
city’s Bureau of Vital Statistics has developed an online 
tool  to  educate  providers  in  all  phases  of  their  careers 
about  death  certificate  completion,  and  other  education 
materials are being developed (12). As the success of these 
efforts are evaluated, it will be important to monitor trends 
in the reporting of CHD deaths on death certificates and to 
assess any changes in the CHD death rates that could be 
due to changes in reporting practices. Meanwhile, CHD is 
the leading cause of death in New York City, and efforts 
to reduce its burden remain a top public health priority. 
Having accurate data will help DOHMH meet its mission 
to protect and promote the health of all New Yorkers.
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Tables
Table 1. ICD-9 and ICD-10 Codes Used to Report CHD as a Cause of Death on Death Certificates, New York City, 2003
Description of ICD-9 Code ICD-9 ICD-10 Description of ICD-10 Code
Included in ARIC studya
Diabetes mellitus 250 E10 Insulin-dependent diabetes mellitus
Diabetes mellitus 250 E11 Non–insulin-dependent diabetes mellitus
Diabetes mellitus 250 E12 Malnutrition-related diabetes mellitus
Diabetes mellitus 250 E13 Other specified diabetes mellitus
Diabetes mellitus 250 E1 Unspecified diabetes mellitus
Essential hypertension 01 I10 Essential hypertension
Hypertensive heart disease 02 I11 Hypertensive heart disease
Angina pectoris 13 I20 Angina pectoris
Acute MI 10 I21 Acute MI
Acute MI 10 I22 Subsequent MI
—b —b I23 Certain current complications following acute MI
Other acute and subacute IHD 11 I2 Other acute IHD
Old MI, other forms of chronic IHD 12, 1, 29.2 I25 Chronic IHD
Cardiac dysrhythmias 27 I6-I9 Cardiac arrest; paroxysmal tachycardia; atrial fibrillation; 
other cardiac arrhythmias
Heart failure 28 I50 Heart failure
Ill-defined descriptions and complications of 
heart disease
29 but not 29.2 I51 Ill-defined complications of heart disease
Atherosclerosis 0 I70 Atherosclerosis
Acute edema of lung, unspecified 518. J81 Pulmonary edema
Sudden death, cause unknown 798 R96 Other sudden death, cause unknown
Other ill-defined and unknown 799 R99 Other ill-defined and unknown cause
 
Abbreviations: ICD-9, International Classification of Diseases, 9th revision; ICD-10, International Classification of Diseases, 10th revision; CHD, coronary heart 
disease; ARIC, Atherosclerosis Risk in Communities; MI, myocardial infarction; IHD, ischemic heart disease. 
a The ARIC study evaluated coronary heart disease reporting on death certificates in  geographically distinct US communities using a blinded medical record 
review process (8). 
b No analogous code.
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Table 2. Characteristics of Decedents for Whom Cause of Death Was Reported as CHD on Death Certificates, New York City, 
2003
Characteristic No. (n = 444) Weighted No. (n = 7,800) Weighted %a
Demographic Characteristics
Sex
Women 29 ,190 5
Men 195 3,610 6
Age, y
<35 2 15 <1
35-7 13 2,66 3
≥75 299 5,121 66
Race/ethnicity
Non-Hispanic white 276 ,262 55
Non-Hispanic black 103 1,81 23
Hispanic 3 1,038 13
Other/missing/unknown 31 686 9
 
Abbreviations: CHD, coronary heart disease; ED, emergency department; DOA, dead on arrival; ICD-10, International Classification of Diseases, 10th revision. 
a Percentages may not total 100 because of rounding. 
b More than 1 ICD code may be recorded per record.
Description of ICD-9 Code ICD-9 ICD-10 Description of ICD-10 Code
Not included in ARIC study
Subarachnoid hemorrhage 30 I60 Subarachnoid hemorrhage
Intracerebral hemorrhage 31 I61 Intracerebral hemorrhage
Other and unspecified intracranial hemorrhage 32 I62 Other nontraumatic intracranial hemorrhage
Cerebral artery occlusion with infarction 3.9 I63 Cerebral infarction
Acute but ill-defined cerebrovascular disease 36 I6 Stroke, not specified as hemorrhage or infarction
Occlusion and stenosis of precerebral arteries 33 I65 Occlusion and stenosis of precerebral arteries
Occlusion of cerebral arteries 3 I66 Occlusion of cerebral arteries
Other and ill-defined cerebrovascular disease 37 I67 Other cerebrovascular diseases
Other and ill-defined cerebrovascular disease 37 I68 Cerebrovascular disease in diseases classified elsewhere
Late effects of cerebrovascular disease 38 I69 Sequelae of cerebrovascular disease
 
Abbreviations: ICD-9, International Classification of Diseases, 9th revision; ICD-10, International Classification of Diseases, 10th revision; CHD, coronary heart 
disease; ARIC, Atherosclerosis Risk in Communities; MI, myocardial infarction; IHD, ischemic heart disease. 
a The ARIC study evaluated coronary heart disease reporting on death certificates in  geographically distinct US communities using a blinded medical record 
review process (8). 
b No analogous code.
Table 1. (continued) ICD-9 and ICD-10 Codes Used to Report CHD as a Cause of Death on Death Certificates, New York City, 
2003
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Characteristic No. (n = 444) Weighted No. (n = 7,800) Weighted %a
Mortality Characteristics
Hospital type
Private 06 6,927 89
Public 38 873 11
Place of death
Inpatient 35 5,923 76
Outpatient/ED/DOA 93 1,776 23
Other place 5 86 1
Unknown 1 15 <1
Death certificate cause of deathb
ICD-10: I20-I25 365 5,773 7
ICD-10: I21 only 63 1,109 1
ICD-10: I25 only 300 ,627 59
Other (not I20-I25) 79 2,027 26
 
Abbreviations: CHD, coronary heart disease; ED, emergency department; DOA, dead on arrival; ICD-10, International Classification of Diseases, 10th revision. 
a Percentages may not total 100 because of rounding. 
b More than 1 ICD code may be recorded per record.
Table 3. Validation Measures of Death Certificate Accuracy for Reporting CHD, New York City, 2003
Characteristic Sensitivitya
Positive Predictive 
Valueb False-Positive Ratec Comparability Ratiod (95% CI)
Definite CHDe
Age, y
35-7 0.77 0.51 0.53 1.51 (1.07-1.95)
75-8 0.88 0.6 0.69 1.9 (1.33-2.55)
≥85 0.98 0.1 0.75 2.37 (1.71-3.02)
 
Abbreviation: CHD, coronary heart disease; CI, confidence interval. 
a CHD defined by death certificate and by validation divided by CHD defined by validation. 
b CHD defined by death certificate and by validation divided by CHD defined by death certificate. 
c CHD defined by death certificate but not by validation divided by all death certificates validated as not CHD. 
d CHD defined by death certificate divided by CHD deaths defined by validation. 
e Defined as 1) no known nonatherosclerotic or noncardiac process or event that was probably lethal and 2) at least 1 of the following conditions: definite myo-
cardial infarction for which the patient was hospitalized within  weeks of death, history of chest pain within 72 hours of death, or history of chronic ischemic 
heart disease such as coronary insufficiency or angina pectoris. 
f Inpatient sample is equivalent to the in-hospital sample excluding outpatient, emergency department, and dead on arrival deaths. 
g Defined as 1) no known nonatherosclerotic or noncardiac process or event that was probably lethal and 2) a death certificate with a consistent underlying 
cause of death.
Table 2. (continued) Characteristics of Decedents for Whom Cause of Death Was Reported as CHD on Death Certificates, 
New York City, 2003
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Characteristic Sensitivitya
Positive Predictive 
Valueb False-Positive Ratec Comparability Ratiod (95% CI)
Definite CHDe (continued) 
Sex
Women 0.88 0.8 0.63 1.83 (1.6-2.20)
Men 0.86 0.3 0.69 2.01 (1.5-2.57)
Race/ethnicity
Non-Hispanic white 0.92 0. 0.72 2.08 (1.66-2.50)
Non-Hispanic black 0.83 0.39 0.59 2.1 (1.21-3.06)
Hispanic 0.83 0.6 0.37 1.30 (0.79-1.81)
Total in-hospital 0.87 0.6 0.66 1.91 (1.59-2.23)
Total inpatientf 0.82 0. 0.66 1.89 (1.9-2.29)
Possible CHDg
Age, y
35-7 0.8 0.78 0.3 1.07 (0.89-1.26)
75-8 0.91 0.62 0.61 1.8 (1.11-1.85)
≥85 0.99 0.61 0.67 1.62 (1.33-1.91)
Sex
Women 0.92 0.69 0.50 1.32 (1.1-1.50)
Men 0.90 0.62 0.59 1. (1.15-1.73)
Race/ethnicity
Non-Hispanic white 0.9 0.61 0.6 1.5 (1.32-1.76)
Non-Hispanic black 0.90 0.72 0.0 1.26 (0.96-1.56)
Hispanic 0.87 0.90 0.13 0.96 (0.75-1.17)
Total in-hospital 0.91 0.66 0.5 1.37 (1.21-1.53)
Total inpatientf 0.86 0.59 0.59 1.6 (1.22-1.70)
 
Abbreviation: CHD, coronary heart disease; CI, confidence interval. 
a CHD defined by death certificate and by validation divided by CHD defined by validation. 
b CHD defined by death certificate and by validation divided by CHD defined by death certificate. 
c CHD defined by death certificate but not by validation divided by all death certificates validated as not CHD. 
d CHD defined by death certificate divided by CHD deaths defined by validation. 
e Defined as 1) no known nonatherosclerotic or noncardiac process or event that was probably lethal and 2) at least 1 of the following conditions: definite myo-
cardial infarction for which the patient was hospitalized within  weeks of death, history of chest pain within 72 hours of death, or history of chronic ischemic 
heart disease such as coronary insufficiency or angina pectoris. 
f Inpatient sample is equivalent to the in-hospital sample excluding outpatient, emergency department, and dead on arrival deaths. 
g Defined as 1) no known nonatherosclerotic or noncardiac process or event that was probably lethal and 2) a death certificate with a consistent underlying 
cause of death.
Table 3. (continued) Validation Measures of Death Certificate Accuracy for Reporting CHD, New York City, 2003